C84.Z0

Clinical Causes: Unknown exact cause, often linked to genetic mutations in T or NK cells Viral infections, such as Epstein-Barr virus (EBV), may play a role Immune system dysfunction or suppression can increase risk Environmental factors, although specific exposures are not well established Certain age groups, including middle-aged and older adults, are more frequently affected

Key Symptoms: Swollen lymph nodes, especially in the neck, armpits, or groin Unexplained weight loss Persistent fever with no evident infection Night sweats Fatigue or feeling unusually tired Pain or discomfort in the affected areas Enlargement of organs such as the spleen or liver Skin lesions or rashes (less common)

Diagnosis Path: Diagnosing other mature T/NK-cell lymphomas involves a combination of clinical evaluation and laboratory tests. Typical diagnostic steps include: - Physical examination to check for lymph node swelling and organ enlargement - Imaging studies, such as CT or PET scans, to determine the extent of disease spread - Biopsy of affected tissue or lymph nodes for microscopic examination - Immunophenotyping to identify specific cellular markers characteristic of T or NK cells - Molecular tests to detect genetic mutations or viral associations Early diagnosis is critical for establishing an appropriate treatment plan and improving outcomes.

Treatment Protocols: Treatment options for this type of lymphoma depend on the disease stage, location, and patient health status. Common approaches include: - Chemotherapy regimens tailored for aggressive lymphomas - Targeted therapies that focus on specific molecular features - Radiation therapy for localized disease - Bone marrow or stem cell transplantation in selected cases - Supportive care to manage symptoms and side effects Given the complexity and rarity of these lymphomas, a multidisciplinary team typically guides treatment decisions. Participation in clinical trials may also be an option for eligible patients.